iiinova — where your digital self keeps evolving

Simon Kraler

@skraler.bsky.social

MD PhD. Prefer climbing to football, cycling to walking, Kinks to Stones. Cardiologist, scientist, editor @EJCI & editorial-board member @EHJ.

Posts Replies Media

Simon Kraler @skraler.bsky.social · 28/08/2025

#ESCCongress 2025 #Global #Health 🇪🇸 Proud to be a #Social #Media #Ambassador for #Acute #Coronary #Syndromes & #CAD – sharing the latest science 🌍Excited to work w/ @drmilicaa @franciscojlk @rafavidalperez @liberale_luca and all other amazing colleagues👇 #CVHealthForAll❤️

120

Reposted by Simon Kraler

Stefanie Dimmeler @stefaniedimmeler.bsky.social · 04/08/2025

🚨 Excited to share that our latest study on the role of inflammatory activation in endothelial cells during the infarct response is now published in Circulation Research! Huge thanks to all co-authors—especially Lukas, Till, Simone, and Ariane—for driving this project forward.

1125

Reposted by Simon Kraler

ISACB @appliedcvb.bsky.social · 23/06/2025

Member publication alert: Vascular (dys)function in the failing heart www.nature.com/articles/s41...

nature.com

Vascular (dys)function in the failing heart - Nature Reviews Cardiology

Coronary and systemic vascular dysfunction contributes to the initiation and progression of heart failure (HF) with or without reduced ejection fraction and, vice versa, HF compromises vascular functi...

011

Simon Kraler @skraler.bsky.social · 14/05/2025

🚨 Now up @escardio.bsky.social Acute coronary syndromes: together w/ @dlbhattmd.bsky.social, C Mueller & P Libby we call for a precision medicine approach 🔹 Diverse mechanisms 🔹 Sex-specific differences 🔹 Shifting risk factor profiles 🔹 AI tools for personalised care doi.org/10.1093/eurh...

254

Reposted by Simon Kraler

NEJM.org @nejm.org · 03/05/2025

Lepodisiran is a long-acting small interfering RNA that blocks hepatic apolipoprotein(a) production. A new Quick Take video covers the ALPACA trial’s findings in patients with elevated lipoprotein(a). 🎥 Watch now: youtu.be/B0aH0O9Pk7Q #MedSky #CardioSky

youtu.be

Lepodisiran: an RNA Targeting Lipoprotein(a) (ALPACA trial) | NEJM

YouTube video by NEJM Group

086